Wei-An Yuan

571 total citations
35 papers, 314 citations indexed

About

Wei-An Yuan is a scholar working on Complementary and alternative medicine, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Wei-An Yuan has authored 35 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Complementary and alternative medicine, 9 papers in Pharmacology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Wei-An Yuan's work include Traditional Chinese Medicine Studies (9 papers), Musculoskeletal pain and rehabilitation (6 papers) and Spine and Intervertebral Disc Pathology (6 papers). Wei-An Yuan is often cited by papers focused on Traditional Chinese Medicine Studies (9 papers), Musculoskeletal pain and rehabilitation (6 papers) and Spine and Intervertebral Disc Pathology (6 papers). Wei-An Yuan collaborates with scholars based in China and United States. Wei-An Yuan's co-authors include Hong Zhang, Xin Luan, Yongfang Zhao, Hongzhuan Chen, Jian‐Guang Xu, Xia Huang, Lili Chen, Jianrong Xu, Jian Jiang and Hongsheng Zhan and has published in prestigious journals such as Frontiers in Pharmacology, BMJ Open and Phytotherapy Research.

In The Last Decade

Wei-An Yuan

31 papers receiving 307 citations

Peers

Wei-An Yuan
Yingchun He China
Kelei Su China
Maoyi Yang China
Lindsay M. Henderson United States
Heping Lei China
Liyun Duan China
Airong Yu China
Jiang Liang-duo China
Lian‐Di Kan China
Yingchun He China
Wei-An Yuan
Citations per year, relative to Wei-An Yuan Wei-An Yuan (= 1×) peers Yingchun He

Countries citing papers authored by Wei-An Yuan

Since Specialization
Citations

This map shows the geographic impact of Wei-An Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-An Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-An Yuan more than expected).

Fields of papers citing papers by Wei-An Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei-An Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-An Yuan. The network helps show where Wei-An Yuan may publish in the future.

Co-authorship network of co-authors of Wei-An Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Wei-An Yuan. A scholar is included among the top collaborators of Wei-An Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei-An Yuan. Wei-An Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Danfei, Qin Zhang, Yan Yan, et al.. (2025). Efficacy and safety of Kunxinning granules in patients with menopausal syndrome: a multicenter, randomized, double-blinded, and placebo-controlled trial. Frontiers in Pharmacology. 16. 1512110–1512110.
2.
Jing, Rui, Wendan Zhang, Jun Xia, et al.. (2025). Icaritin Improves the Hematopoiesis-Supportive Function of MSCs via A PRDX1–MAPK Axis After Chemotherapy. Engineering. 54. 261–276.
3.
Tang, Yaqin, et al.. (2024). [Guidelines for quality control of human use experience study on traditional Chinese medicine].. PubMed. 49(17). 4801–4804. 1 indexed citations
4.
Zhao, Xu, Zhong-Qi Yang, Junhua Zhang, et al.. (2024). [Integrated evidence chain: a new strategy and methodology for effectiveness e valuation of traditional Chinese medicines].. PubMed. 49(19). 5113–5124.
5.
Zhang, Yujie, et al.. (2023). A bibliometric analysis of inflammation in sarcopenia from 2007 to 2022. Experimental Gerontology. 183. 112316–112316. 7 indexed citations
6.
7.
8.
9.
10.
11.
Qu, Liping, Jianyuan Tang, Lei Zhang, et al.. (2022). [Category of Chinese medicine registration:historical evolution,current status,and problems].. PubMed. 47(2). 562–568. 2 indexed citations
12.
Zou, Chong, Hong Ding, Rui Gao, et al.. (2021). [Consensus on collaborative ethical review of multi-center clinical trials of new drugs of traditional Chinese medicine (version 1.0)].. PubMed. 46(7). 1696–1700. 1 indexed citations
13.
Li, Yuanyuan, Hua Zhang, Leilei Zhu, et al.. (2021). Pharmacokinetics-based comprehensive strategy to identify multiple effective components in Huangqi decoction against liver fibrosis. Phytomedicine. 84. 153513–153513. 29 indexed citations
14.
Yang, Zhong-Qi, Yaqin Tang, Yanping Du, et al.. (2021). [Theoretical thinking on guiding research and development of new drugs of traditional Chinese medicine].. China Journal of Chinese Materia Medica. 46(7). 1686–1690. 3 indexed citations
15.
Yang, Zhong-Qi, Yaqin Tang, Yanping Du, et al.. (2021). [Development of clinical trial of new drugs of traditional Chinese medicines].. China Journal of Chinese Materia Medica. 46(7). 1691–1695. 5 indexed citations
16.
Zhang, Wei, Xing Zhang, Xuan Chen, et al.. (2021). Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: A retrospective cohort study. Journal of Integrative Medicine. 19(3). 226–231. 13 indexed citations
17.
Chen, Lili, Xia Huang, Jianrong Xu, et al.. (2020). Combating COVID-19 with integrated traditional Chinese and Western medicine in China. Acta Pharmaceutica Sinica B. 10(7). 1149–1162. 128 indexed citations
18.
Tan, Wenli, Wei Wang, Yilei Chen, et al.. (2020). Spinal Manipulative Therapy Alters Brain Activity in Patients With Chronic Low Back Pain: A Longitudinal Brain fMRI Study. Frontiers in Integrative Neuroscience. 14. 534595–534595. 12 indexed citations
19.
Tan, Bo, Wei-An Yuan, Yue Li, et al.. (2017). Simultaneous determination of glipizide and its four hydroxylated metabolites in human urine using LC–MS/MS and its application in urinary phenotype study. Journal of Pharmaceutical and Biomedical Analysis. 139. 179–186. 9 indexed citations
20.
He, Min, Yu Wu, Mengmeng Wang, et al.. (2015). The Clinical Value of Oxymatrine in Preventing Lamivudine Induced YMDD Mutation: A Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2015. 1–10. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingchun He Breakdown of academic impact, for papers by Kelei Su Breakdown of academic impact, for papers by Maoyi Yang Breakdown of academic impact, for papers by Lindsay M. Henderson Breakdown of academic impact, for papers by Heping Lei Breakdown of academic impact, for papers by Liyun Duan Breakdown of academic impact, for papers by Airong Yu Breakdown of academic impact, for papers by Jiang Liang-duo Breakdown of academic impact, for papers by Lian‐Di Kan
Rankless by CCL
2026